Anticoagulation in AF Following PCI: Guideline Updates and Real-World Evidence
Published: 06 November 2020
-
Views:
44
-
Likes:
7
-
Views:
44
-
Likes:
7
Overview
This programme focuses upon recent data related to use of oral anticoagulants in AF patients following PCI, as well as updates to the ESC Guidelines for clinical practice.
This discussion was funded by an unrestricted educational service from Boehringer Ingelheim
Learning Objectives
- Summarise the Recent Updates to the European Society of Cardiology Atrial Fibrillation Guidelines
- State the Clinical Studies That Have Influenced the Recent Guideline Updates
- Recall the Different Study Designs Used in Pivotal Clinical Trials Assessing NOAC Use Post-PCI
More from this programme
Part 1
Managing AF Following PCI: Interpreting ESC Guideline Updates
Part 2
Real World Outcomes in AF Patients Undergoing PCI
Faculty Biographies
Jan Steffel
Prof Jan Steffel is Vice Chairman of the Department of Cardiology at the University Heart Center, at the University of Zurich. He trained in invasive electrophysiology and devices in Lausanne, Boston, and Munich. Prof Steffel has authored or co-authored over one hundred articles.